Background Hepatitis D virus (also known as hepatitis delta virus) can establish a persistent
infection in people with chronic hepatitis B, leading to accelerated progression of liver …

International sustainable development goals for the elimination of viral hepatitis as a public
health problem by 2030 highlight the pressing need to optimize strategies for prevention …

Hepatitis B virus (HBV) is divided into nine genotypes, A to I. Currently, it remains unclear
how the individual genotypes contribute to the estimated 250 million chronic HBV infections …

There is progressive concern about the evolving burden of morbidity and mortality caused
by coinfection with HIV-1 and hepatitis B virus (HBV) in sub-Saharan Africa, but the …

Background. Antiretroviral treatment (ART) programs in sub-Saharan Africa have for many
years included lamivudine as the sole hepatitis B virus (HBV) inhibitor. Long-term outcomes …

Abstract Background The World Health Organization (WHO) has targeted a reduction in viral
hepatitis-related mortality by 65% and incidence by 90% by 2030, necessitating enhanced …

Background Viral hepatitis is an important public health issue in sub-Saharan Africa. Due to
rising mortality from cirrhosis and hepatocellular carcinoma and limited implementation of …

Background Few data on the virological determinants of hepatitis B virus (HBV) infection are
available from southern Africa. Methods We enrolled consecutive HIV-infected adult patients …

In Gabon, a central African country, human immunodeficiency virus (HIV) and hepatitis B
virus (HBV) are endemic. In a recent study, conducted in a semi-urban area (Franceville …

Background. Hepatitis B virus (HBV) is the leading cause of liver‐related diseases. In
Uganda, there is a regional disparity in the HBV burden. Our study was aimed at …